BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pilzweger C, Holdenrieder S. Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases. Diagnostics (Basel) 2015;5:219-53. [PMID: 26854151 DOI: 10.3390/diagnostics5020219] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yaghouti N, Boostani R, Mohamamdi A, Poursina Z, Rezaee SA, Vakili V, Valizadeh N, Shams A, Rafatpanah H. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection. Viral Immunol 2019;32:89-94. [PMID: 30585773 DOI: 10.1089/vim.2018.0048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Franzini A, Pomicter AD, Yan D, Khorashad JS, Tantravahi SK, Than H, Ahmann JM, O'Hare T, Deininger MW. The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations. Blood Adv 2019;3:2949-61. [PMID: 31648319 DOI: 10.1182/bloodadvances.2019000585] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
3 Vitaliti G, Pavone P, Marino S, Saporito MAN, Corsello G, Falsaperla R. Molecular Mechanism Involved in the Pathogenesis of Early-Onset Epileptic Encephalopathy. Front Mol Neurosci 2019;12:118. [PMID: 31156384 DOI: 10.3389/fnmol.2019.00118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
4 Garrido MM, Bernardino RM, Marta JC, Holdenrieder S, Guimarães JT. Tumour markers of prostate cancer: The post-PSA era. Ann Clin Biochem 2021;:45632211041890. [PMID: 34463154 DOI: 10.1177/00045632211041890] [Reference Citation Analysis]
5 Ramezani A, Aghakhani A, Soleymani S, Bavand A, Bolhassani A. Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women. BMC Infect Dis 2019;19:142. [PMID: 30755156 DOI: 10.1186/s12879-019-3780-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Ding J, Cui X, Liu Q. Emerging role of HMGB1 in lung diseases: Friend or foe. J Cell Mol Med. 2017;21:1046-1057. [PMID: 28039939 DOI: 10.1111/jcmm.13048] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
7 Michel M, Fiebich BL, Kuzior H, Meixensberger S, Berger B, Maier S, Nickel K, Runge K, Denzel D, Pankratz B, Schiele MA, Domschke K, van Elst LT, Endres D. Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression. Transl Psychiatry 2021;11:308. [PMID: 34021122 DOI: 10.1038/s41398-021-01423-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Walker LE, Janigro D, Heinemann U, Riikonen R, Bernard C, Patel M. WONOEP appraisal: Molecular and cellular biomarkers for epilepsy.Epilepsia. 2016;57:1354-1362. [PMID: 27374986 DOI: 10.1111/epi.13460] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
9 Venereau E, De Leo F, Mezzapelle R, Careccia G, Musco G, Bianchi ME. HMGB1 as biomarker and drug target. Pharmacol Res 2016;111:534-44. [PMID: 27378565 DOI: 10.1016/j.phrs.2016.06.031] [Cited by in Crossref: 124] [Cited by in F6Publishing: 121] [Article Influence: 20.7] [Reference Citation Analysis]
10 Hurtgen BJ, Ward CL, Leopold Wager CM, Garg K, Goldman SM, Henderson BEP, McKinley TO, Greising SM, Wenke JC, Corona BT. Autologous minced muscle grafts improve endogenous fracture healing and muscle strength after musculoskeletal trauma. Physiol Rep 2017;5:e13362. [PMID: 28747511 DOI: 10.14814/phy2.13362] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
11 Liu J, Wei E, Wei J, Zhou W, Webster KA, Zhang B, Li D, Zhang G, Wei Y, Long Y, Qi X, Zhang Q, Xu D. MiR-126-HMGB1-HIF-1 Axis Regulates Endothelial Cell Inflammation during Exposure to Hypoxia-Acidosis. Dis Markers 2021;2021:4933194. [PMID: 34970357 DOI: 10.1155/2021/4933194] [Reference Citation Analysis]
12 Kipfmueller F, Heindel K, Geipel A, Berg C, Bartmann P, Reutter H, Mueller A, Holdenrieder S. Expression of soluble receptor for advanced glycation end products is associated with disease severity in congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol 2019;316:L1061-9. [PMID: 30838867 DOI: 10.1152/ajplung.00359.2018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Chin VK, Chuah YK, Lee TY, Nordin N, Ibraheem ZO, Zakaria ZA, Hassan H, Basir R. RAGE modulatory effects on cytokines network and histopathological conditions in malarial mice. Exp Parasitol 2020;216:107946. [PMID: 32622941 DOI: 10.1016/j.exppara.2020.107946] [Reference Citation Analysis]
14 Wang J, Li R, Peng Z, Hu B, Rao X, Li J. HMGB1 participates in LPS‑induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF‑κB signaling pathways. Int J Mol Med 2020;45:61-80. [PMID: 31746367 DOI: 10.3892/ijmm.2019.4402] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
15 Soong L. Dysregulated Th1 Immune and Vascular Responses in Scrub Typhus Pathogenesis. J Immunol 2018;200:1233-40. [PMID: 29431689 DOI: 10.4049/jimmunol.1701219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
16 Kotsiou OS, Jagirdar RM, Papazoglou ED, Hatzoglou C, Gourgoulianis KI, Zarogiannis SG. HΜGB1/sRAGE levels differ significantly between transudates and exudates. Cytokine 2021;141:155469. [PMID: 33607399 DOI: 10.1016/j.cyto.2021.155469] [Reference Citation Analysis]
17 Garrido MM, Ribeiro RM, Krüger K, Pinheiro LC, Guimarães JT, Holdenrieder S. Relevance of Circulating Nucleosomes, HMGB1 and sRAGE for Prostate Cancer Diagnosis. In Vivo 2021;35:2207-12. [PMID: 34182498 DOI: 10.21873/invivo.12492] [Reference Citation Analysis]
18 Hykollari A, Malzl D, Eckmair B, Vanbeselaere J, Scheidl P, Jin C, Karlsson NG, Wilson IBH, Paschinger K. Isomeric Separation and Recognition of Anionic and Zwitterionic N-glycans from Royal Jelly Glycoproteins. Mol Cell Proteomics 2018;17:2177-96. [PMID: 30104209 DOI: 10.1074/mcp.RA117.000462] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
19 Feng Y, Weng H, Ling L, Zeng T, Zhang Y, Chen D, Li H. Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice. International Journal of Biological Macromolecules 2019;132:1001-11. [DOI: 10.1016/j.ijbiomac.2019.03.242] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
20 Dlugos D, Worrell G, Davis K, Stacey W, Szaflarski J, Kanner A, Sunderam S, Rogawski M, Jackson-Ayotunde P, Loddenkemper T, Diehl B, Fureman B, Dingledine R; Epilepsy Benchmark Stewards. 2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. Epilepsy Curr 2016;16:192-7. [PMID: 27330452 DOI: 10.5698/1535-7511-16.3.192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Bell RF, Moreira VM, Kalso EA, Yli-Kauhaluoma J. Liquorice for pain? Ther Adv Psychopharmacol 2021;11:20451253211024873. [PMID: 34349979 DOI: 10.1177/20451253211024873] [Reference Citation Analysis]
22 Schueler J, Klingner K, Bug D, Zoeller C, Maier A, Dong M, Willecke K, Peille AL, Steiner E, Landesfeind M, Copland JA, Siegers GM, Haferkamp A, Boehm K, Tsaur I, Schneider M. Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development. Oncotarget 2018;9:30946-61. [PMID: 30123419 DOI: 10.18632/oncotarget.25697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Handke NA, Rupp ABA, Trimpop N, von Pawel J, Holdenrieder S. Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients. Diagnostics (Basel) 2021;11:356. [PMID: 33672622 DOI: 10.3390/diagnostics11020356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Muhammad S, Chaudhry SR, Kahlert UD, Lehecka M, Korja M, Niemelä M, Hänggi D. Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review. Int J Mol Sci 2020;21:E2709. [PMID: 32295146 DOI: 10.3390/ijms21082709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Soong L, Shelite TR, Xing Y, Kodakandla H, Liang Y, Trent BJ, Horton P, Smith KC, Zhao Z, Sun J, Bouyer DH, Cai J. Type 1-skewed neuroinflammation and vascular damage associated with Orientia tsutsugamushi infection in mice. PLoS Negl Trop Dis 2017;11:e0005765. [PMID: 28742087 DOI: 10.1371/journal.pntd.0005765] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
26 Bent R, Moll L, Grabbe S, Bros M. Interleukin-1 Beta-A Friend or Foe in Malignancies? Int J Mol Sci 2018;19:E2155. [PMID: 30042333 DOI: 10.3390/ijms19082155] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 21.8] [Reference Citation Analysis]
27 Whittall-García LP, Torres-Ruiz J, Zentella-Dehesa A, Tapia-Rodríguez M, Alcocer-Varela J, Mendez-Huerta N, Gómez-Martín D. Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features. Lupus 2019;28:1549-57. [PMID: 31619143 DOI: 10.1177/0961203319883936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
28 Egron C, Roszyk L, Rochette E, Jabaudon M, Sapin V, Mulliez A, Labbé A, Coste K. Serum soluble receptor for advanced glycation end-products during acute bronchiolitis in infant: Prospective study in 93 cases. Pediatr Pulmonol 2018;53:1429-35. [PMID: 30113140 DOI: 10.1002/ppul.24141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
29 Xue J, Suarez JS, Minaai M, Li S, Gaudino G, Pass HI, Carbone M, Yang H. HMGB1 as a therapeutic target in disease. J Cell Physiol 2021;236:3406-19. [PMID: 33107103 DOI: 10.1002/jcp.30125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
30 Máca J, Burša F, Ševčík P, Sklienka P, Burda M, Holub M. Alarmins and Clinical Outcomes After Major Abdominal Surgery-A Prospective Study. J Invest Surg 2017;30:152-61. [PMID: 27689623 DOI: 10.1080/08941939.2016.1231855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]